Published in:
Open Access 01-12-2018 | Correction
Correction to: In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study
Published in: BMC Medicine | Issue 1/2018
Login to get accessExcerpt
The original article [1] contains errors in Table 1 affecting some of the presented oligonucleotide sequences and readthrough values in Table 1.
Table 1
Oligonucleotide sequences used in the dual reporter gene assay, corresponding to the Y122X, G542X, R1162X and W1292X mutations and the TQ in frame control. Readthrough level before and after incubation with 600 μg/ml gentamicin
|
Mutation
|
Oligonucleotide
|
0
|
600
|
|---|---|---|---|
|
Y122X
|
w 5’ TCTATCGCGATTTAACTAGGCATAGGC 3′
c 5’ GCCTATGCCTAGTTAAATCGCGATAGA 3′
|
0.02
|
0.12
|
|
W1282X
|
w 5’ACTTTGCAACAGTGAAGGAAAGCCTTT 3′
c 5’AAAGGCTTTCCTTCACTGTTGCAAAGT 3’
|
0.115
|
0. 35
|
|
R1162X
|
w 5’CGATCTGTGAGCTGAGTCTTTAAGTTC 3′
c 5’GAACTTAAAGACTCAGCTCACAGATCG 3′
|
0.023
|
0.22
|
|
G542X
|
w 5’AATATAGTTCTTTGAGAAGGTGGAATC 3′
c 5’GATTCCACCTTCTCAAAGAACTATATT 3′
|
0.017
|
0.26
|